SC Health has announced a business combination with Rockley Photonics Ltd.

Company Website
Press Release
Investor Presentation
Investor Call Transcript
S-4 Proxy

ABOUT US

SC Health Corporation (“SC Health”) is a Special Purpose Acquisition Company (SPAC) incorporated in the Cayman Islands.

On March 19, 2021, SC Health announced a business combination with Rockley Photonics, Ltd. (“Rockley”), a leading global supplier of integrated silicon photonic chips and modules across multiple markets. The transaction will accelerate the commercial launch of Rockley’s unique sensing platform, which is positioned to revolutionize consumer health and wellness by enabling continuous, non-invasive monitoring of multi-modal biomarkers such as lactate, glucose, hydration, blood pressure, and core body temperature.

SC Health believes Rockley’s transformational technology will revolutionize consumers’ ability to track, monitor and better understand their day-to-day health and wellness. Based on Rockley’s large addressable market, world-class team, and the myriad applications that their silicon photonics platform enables, SC Health views Rockley as one of the most compelling opportunities in the entire healthcare space.

BUSINESS STRATEGY

We will identify and complete an initial business combination with a company that complements the experience and skills of our management team and can benefit from our operational expertise.

We intend to:

  • Execute a platform-building strategy to build out investments in close alignment with the management of our acquisition target in the healthcare space
  • Leverage our management team’s and SINCap’s broad and deep network of relationships, unique industry expertise and proven deal-sourcing capabilities to ensure a strong and differentiated pipeline of targets
  • Scale the combined business platform by leveraging our management team’s and SINCap’s expertise and capabilities

Our sponsor is an affiliate of SIN Capital (“SINCap”), a Pan-Asia multi-asset professional investment firm with a differentiated investment approach centered around several key tenets:

SINCap’s strategy is focused on private investments in healthcare through its portfolio company, Fullerton Healthcare Corporation Limited; education; agri-business; advanced manufacturing; and prime real estate across gateway cities in Asia.

SINCap is led by its Chief Executive Officer, David Sin, and a management team comprising professionals with global institutional experience gained from prior roles at leading investment institutions, including Goldman Sachs and Credit Suisse. Collectively, this team possesses extensive international investment and corporate finance experience across global financial centers including New York, London, Hong Kong and Singapore.